Alzamend Neuro Correlations
ALZN Stock | USD 0.67 0.02 3.30% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alzamend Neuro moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alzamend Neuro moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Alzamend Neuro Correlation With Market
Modest diversification
The correlation between Alzamend Neuro and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alzamend Neuro and DJI in the same portfolio, assuming nothing else is changed.
Alzamend |
Moving together with Alzamend Stock
0.66 | ENVB | Enveric Biosciences | PairCorr |
0.69 | EVO | Evotec SE ADR | PairCorr |
0.75 | KZR | Kezar Life Sciences | PairCorr |
0.77 | ZURA | Zura Bio Limited | PairCorr |
0.84 | IMMX | Immix Biopharma | PairCorr |
0.79 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.86 | MNOV | MediciNova | PairCorr |
0.61 | MOLN | Molecular Partners | PairCorr |
0.87 | NKTX | Nkarta Inc Earnings Call This Week | PairCorr |
0.79 | PALI | Palisade Bio | PairCorr |
0.84 | PHVS | Pharvaris BV | PairCorr |
0.71 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.76 | RGNX | Regenxbio | PairCorr |
0.76 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.73 | RYTM | Rhythm Pharmaceuticals | PairCorr |
0.84 | APLS | Apellis Pharmaceuticals | PairCorr |
0.79 | SUPN | Supernus Pharmaceuticals | PairCorr |
0.75 | TERN | Terns Pharmaceuticals | PairCorr |
Moving against Alzamend Stock
0.82 | IVA | Inventiva Sa | PairCorr |
0.71 | LLY | Eli Lilly | PairCorr |
0.57 | PBH | Prestige Brand Holdings | PairCorr |
0.52 | KRYS | Krystal Biotech | PairCorr |
0.44 | VIGL | Vigil Neuroscience | PairCorr |
0.43 | MGTX | MeiraGTx Holdings PLC Trending | PairCorr |
0.9 | ABBV | AbbVie Inc Sell-off Trend | PairCorr |
0.85 | BAX | Baxter International | PairCorr |
0.68 | MDT | Medtronic PLC | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alzamend Stock performing well and Alzamend Neuro Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alzamend Neuro's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
TCON | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SLDB | 4.92 | 0.63 | 0.10 | 0.19 | 4.74 | 11.61 | 39.92 | |||
KZR | 1.94 | (0.17) | 0.00 | (0.39) | 0.00 | 3.75 | 12.35 | |||
SNTI | 4.84 | (0.75) | 0.00 | (2.55) | 0.00 | 11.46 | 40.68 | |||
XFOR | 7.66 | 0.43 | 0.06 | (1.79) | 7.80 | 26.42 | 68.45 | |||
INZY | 4.18 | (1.01) | 0.00 | (0.84) | 0.00 | 7.72 | 38.13 | |||
TERN | 3.03 | (0.80) | 0.00 | (0.97) | 0.00 | 5.03 | 20.46 | |||
DAWN | 2.66 | (0.49) | 0.00 | (0.62) | 0.00 | 4.59 | 22.86 | |||
HOOK | 3.62 | (0.91) | 0.00 | (15.63) | 0.00 | 7.00 | 32.80 |
Alzamend Neuro Corporate Management
Henry Esq | General VP | Profile | |
Kenneth CPA | Senior Finance | Profile | |
David Katzoff | Chief Officer | Profile | |
Stephan Jackman | CEO Director | Profile |